Merus N.V. Announces Proposed Public Offering of Common Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/20/2026
- Wall Street indexes fall, with Iran and earnings season in focus
- Oil settles 1% higher as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- NVIDIA reports 9.3% passive stake in Nebius
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
Merus N.V. (MRUS) PT Raised to $85 at H.C. Wainwright
May 29, 2024 6:20 AM EDTH.C. Wainwright analyst Andrew Fein raised the price target on Merus N.V. (NASDAQ: MRUS) to $85.00 (from $65.00) while maintaining a Buy rating.
The analyst comments "Valuation and risks to reaching our price target. Given the recent ASCO update for petosemtamab, we are... More
Merus N.V. (MRUS) PT Raised to $80 at BofA Securities
May 29, 2024 5:13 AM EDTBofA Securities analyst Tazeen Ahmad raised the price target on Merus N.V. (NASDAQ: MRUS) to $80.00 (from $61.00) while maintaining a Buy rating.
The analyst comments "Merus reported 67% objective response rate (ORR; 1 CR, 15 PR) in 24 evaluable 1L head and neck squamous cell carcinoma (HNSCC)... More
